Evidence-informed pharmacology monograph, updated 10 November 2026. For medical education; individual management requires current product labeling and qualified clinical assessment.
Clinical overview
Adenosine is an endogenous purine nucleoside and a very short-acting intravenous antiarrhythmic that transiently suppresses AV-node conduction. It is most useful for terminating specific regular AV-node-dependent supraventricular tachycardias (SVTs); its coronary vasodilator action is also exploited with different infusion regimens for pharmacologic stress imaging. It is not a routine treatment for myocardial infarction, ischemic stroke or cancer [1,2].
Receptor pharmacology
Four adenosine receptors are recognized: A1 and A3 mainly couple to Gi/o, whereas A2A and A2B mainly activate Gs signaling. In the AV node, A1 activation increases potassium conductance and reduces calcium-dependent conduction and cAMP signaling, transiently interrupting AV nodal re-entry. A2A-mediated vascular smooth-muscle relaxation increases coronary blood flow in diagnostic stress protocols. Caffeine and theophylline antagonize receptor signaling; dipyridamole inhibits adenosine uptake and can increase its effects [1].
Indications and limitations
For a stable, regular narrow-complex tachycardia consistent with AVNRT or orthodromic AVRT, appropriate vagal maneuvers are generally attempted first, then adenosine can be administered by trained staff with ECG monitoring and resuscitation equipment. Adenosine does not reliably convert atrial fibrillation, atrial flutter or ventricular tachycardia to sinus rhythm; a transient slowing may instead help reveal atrial activity. Avoid adenosine in irregular or polymorphic wide-complex tachycardia and in suspected pre-excited atrial fibrillation because dangerous ventricular rhythms may occur [1,2].
Pharmacokinetics and administration
Adenosine is rapidly taken up and metabolized by vascular endothelium and erythrocytes, with a plasma half-life of less than about ten seconds. For SVT it must be delivered as a rapid IV bolus followed by a flush through a suitable line; slow injection may be ineffective. Diagnostic stress infusions use distinct doses and have their own contraindications. An unstable patient needs immediate resuscitation and synchronized cardioversion when indicated rather than delaying definitive care [1,2].
Adverse reactions and contraindications
Brief flushing, chest discomfort, dyspnea and a sensation of impending doom are common. Important risks include profound AV block, transient asystole, bronchospasm and serious arrhythmias. Second- or third-degree AV block or sick-sinus syndrome without a functioning pacemaker are contraindications; avoid use in patients with active bronchospasm/asthma based on product-specific warnings. Careful monitoring is needed with digoxin, verapamil or other conduction-active drugs [1,2].
Learning points
Do not present adenosine as a general anti-ischemic or neuroprotective treatment. Distinguish the bolus antiarrhythmic indication from prolonged vasodilator stress testing, and explain that its very short duration does not eliminate potentially serious acute reactions [1,2].
References
- Brunton LL, Knollmann BC, editors. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 14th ed. McGraw Hill; 2023.
- DailyMed. Adenosine injection: prescribing information, including PSVT indication and precautions. Updated August 31, 2026. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9508caf5-0e3a-4d32-909d-bff7ea40ec30
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.